1. Home
  2. GNFT vs PCYO Comparison

GNFT vs PCYO Comparison

Compare GNFT & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • PCYO
  • Stock Information
  • Founded
  • GNFT 1999
  • PCYO 1976
  • Country
  • GNFT France
  • PCYO United States
  • Employees
  • GNFT N/A
  • PCYO N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • PCYO Water Supply
  • Sector
  • GNFT Health Care
  • PCYO Utilities
  • Exchange
  • GNFT Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • GNFT 249.0M
  • PCYO 254.1M
  • IPO Year
  • GNFT 2019
  • PCYO N/A
  • Fundamental
  • Price
  • GNFT $6.06
  • PCYO $10.80
  • Analyst Decision
  • GNFT Strong Buy
  • PCYO
  • Analyst Count
  • GNFT 1
  • PCYO 0
  • Target Price
  • GNFT $13.00
  • PCYO N/A
  • AVG Volume (30 Days)
  • GNFT 21.7K
  • PCYO 42.4K
  • Earning Date
  • GNFT 09-19-2024
  • PCYO 11-13-2024
  • Dividend Yield
  • GNFT N/A
  • PCYO N/A
  • EPS Growth
  • GNFT N/A
  • PCYO N/A
  • EPS
  • GNFT 0.47
  • PCYO 0.25
  • Revenue
  • GNFT $86,225,222.00
  • PCYO $19,555,000.00
  • Revenue This Year
  • GNFT $155.44
  • PCYO N/A
  • Revenue Next Year
  • GNFT N/A
  • PCYO N/A
  • P/E Ratio
  • GNFT $11.74
  • PCYO $42.31
  • Revenue Growth
  • GNFT 175.45
  • PCYO N/A
  • 52 Week Low
  • GNFT $2.97
  • PCYO $8.94
  • 52 Week High
  • GNFT $6.08
  • PCYO $11.32
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 69.91
  • PCYO 56.24
  • Support Level
  • GNFT $5.41
  • PCYO $10.48
  • Resistance Level
  • GNFT $5.84
  • PCYO $10.86
  • Average True Range (ATR)
  • GNFT 0.30
  • PCYO 0.26
  • MACD
  • GNFT 0.04
  • PCYO -0.02
  • Stochastic Oscillator
  • GNFT 98.03
  • PCYO 68.47

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: